TODD STRATEGY GROUP

Lobbying for VAXART INC. · Clinical-stage biotechnology company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · $60,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Medical/Disease Research/Clinical Labs

Vaccine policy.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem